PKC Signaling Regulates Drug Resistance of the Fungal Pathogen via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
Fungal pathogens exploit diverse mechanisms to survive exposure to antifungal drugs. This poses concern given the limited number of clinically useful antifungals and the growing population of immunocompromised individuals vulnerable to life-threatening fungal infection. To identify molecules that abrogate resistance to the most widely deployed class of antifungals, the azoles, we conducted a screen of 1,280 pharmacologically active compounds. Three out of seven hits that abolished azole resistance of a resistant mutant of the model yeast Saccharomyces cerevisiae and a clinical isolate of the leading human fungal pathogen Candida albicans were inhibitors of protein kinase C (PKC), which regulates cell wall integrity during growth, morphogenesis, and response to cell wall stress. Pharmacological or genetic impairment of Pkc1 conferred hypersensitivity to multiple drugs that target synthesis of the key cell membrane sterol ergosterol, including azoles, allylamines, and morpholines. Pkc1 enabled survival of cell membrane stress at least in part via the mitogen activated protein kinase (MAPK) cascade in both species, though through distinct downstream effectors. Strikingly, inhibition of Pkc1 phenocopied inhibition of the molecular chaperone Hsp90 or its client protein calcineurin. PKC signaling was required for calcineurin activation in response to drug exposure in S. cerevisiae. In contrast, Pkc1 and calcineurin independently regulate drug resistance via a common target in C. albicans. We identified an additional level of regulatory control in the C. albicans circuitry linking PKC signaling, Hsp90, and calcineurin as genetic reduction of Hsp90 led to depletion of the terminal MAPK, Mkc1. Deletion of C. albicans PKC1 rendered fungistatic ergosterol biosynthesis inhibitors fungicidal and attenuated virulence in a murine model of systemic candidiasis. This work establishes a new role for PKC signaling in drug resistance, novel circuitry through which Hsp90 regulates drug resistance, and that targeting stress response signaling provides a promising strategy for treating life-threatening fungal infections.
Vyšlo v časopise:
PKC Signaling Regulates Drug Resistance of the Fungal Pathogen via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001069
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001069
Souhrn
Fungal pathogens exploit diverse mechanisms to survive exposure to antifungal drugs. This poses concern given the limited number of clinically useful antifungals and the growing population of immunocompromised individuals vulnerable to life-threatening fungal infection. To identify molecules that abrogate resistance to the most widely deployed class of antifungals, the azoles, we conducted a screen of 1,280 pharmacologically active compounds. Three out of seven hits that abolished azole resistance of a resistant mutant of the model yeast Saccharomyces cerevisiae and a clinical isolate of the leading human fungal pathogen Candida albicans were inhibitors of protein kinase C (PKC), which regulates cell wall integrity during growth, morphogenesis, and response to cell wall stress. Pharmacological or genetic impairment of Pkc1 conferred hypersensitivity to multiple drugs that target synthesis of the key cell membrane sterol ergosterol, including azoles, allylamines, and morpholines. Pkc1 enabled survival of cell membrane stress at least in part via the mitogen activated protein kinase (MAPK) cascade in both species, though through distinct downstream effectors. Strikingly, inhibition of Pkc1 phenocopied inhibition of the molecular chaperone Hsp90 or its client protein calcineurin. PKC signaling was required for calcineurin activation in response to drug exposure in S. cerevisiae. In contrast, Pkc1 and calcineurin independently regulate drug resistance via a common target in C. albicans. We identified an additional level of regulatory control in the C. albicans circuitry linking PKC signaling, Hsp90, and calcineurin as genetic reduction of Hsp90 led to depletion of the terminal MAPK, Mkc1. Deletion of C. albicans PKC1 rendered fungistatic ergosterol biosynthesis inhibitors fungicidal and attenuated virulence in a murine model of systemic candidiasis. This work establishes a new role for PKC signaling in drug resistance, novel circuitry through which Hsp90 regulates drug resistance, and that targeting stress response signaling provides a promising strategy for treating life-threatening fungal infections.
Zdroje
1. BahnYS
XueC
IdnurmA
RutherfordJC
HeitmanJ
2007 Sensing the environment: lessons from fungi. Nat Rev Microbiol 5 57 69
2. CowenLE
SteinbachWJ
2008 Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 7 747 764
3. CamilliA
BasslerBL
2006 Bacterial small-molecule signaling pathways. Science 311 1113 1116
4. HoganDA
2006 Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot Cell 5 613 619
5. KellerNP
TurnerG
BennettJW
2005 Fungal secondary metabolism - from biochemistry to genomics. Nat Rev Microbiol 3 937 947
6. RileyMA
WertzJE
2002 Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56 117 137
7. YimG
WangHH
DaviesJ
2007 Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci 362 1195 1200
8. ButlerMS
BussAD
2006 Natural products–the future scaffolds for novel antibiotics? Biochem Pharmacol 71 919 929
9. LamKS
2007 New aspects of natural products in drug discovery. Trends Microbiol 15 279 289
10. EnochDA
LudlamHA
BrownNM
2006 Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 55 809 818
11. WilsonLS
ReyesCM
StolpmanM
SpeckmanJ
AllenK
2002 The direct cost and incidence of systemic fungal infections. Value Health 5 26 34
12. McNeilMM
NashSL
HajjehRA
PhelanMA
ConnLA
2001 Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis 33 641 647
13. PfallerMA
DiekemaDJ
2007 Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 133 163
14. ZaoutisTE
ArgonJ
ChuJ
BerlinJA
WalshTJ
2005 The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41 1232 1239
15. BaldaufSL
PalmerJD
1993 Animals and fungi are each other's closest relatives: congruent evidence from multiple proteins. Proc Natl Acad Sci U S A 90 11558 11562
16. WainrightPO
HinkleG
SoginML
StickelSK
1993 Monophyletic origins of the metazoa: an evolutionary link with fungi. Science 260 340 342
17. AndersonJB
SirjusinghC
ParsonsAB
BooneC
WickensC
2003 Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics 163 1287 1298
18. CowenLE
2008 The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol 6 187 198
19. AndersonJB
2005 Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3 547 556
20. CowenLE
2009 Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathog 5 e1000471
21. PearlLH
ProdromouC
2006 Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75 271 294
22. PrattWB
ToftDO
2003 Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228 111 133
23. WandingerSK
RichterK
BuchnerJ
2008 The Hsp90 chaperone machinery. J Biol Chem 283 18473 18477
24. CowenLE
CarpenterAE
MatangkasombutO
FinkGR
LindquistS
2006 Genetic architecture of Hsp90-dependent drug resistance. Eukaryot Cell 5 2184 2188
25. CowenLE
LindquistS
2005 Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309 2185 2189
26. ImaiJ
YaharaI
2000 Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin. Mol Cell Biol 20 9262 9270
27. SinghSD
RobbinsN
ZaasAK
SchellWA
PerfectJR
2009 Hsp90 governs echinocadin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5 e1000532
28. FuchsBB
MylonakisE
2009 Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways. Eukaryot Cell 8 1616 1625
29. HeinischJJ
2005 Baker's yeast as a tool for the development of antifungal kinase inhibitors–targeting protein kinase C and the cell integrity pathway. Biochim Biophys Acta 1754 171 182
30. LevinDE
2005 Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69 262 291
31. ZhaoX
MehrabiR
XuJR
2007 Mitogen-activated protein kinase pathways and fungal pathogenesis. Eukaryot Cell 6 1701 1714
32. ParaviciniG
MendozaA
AntonssonB
CooperM
LosbergerC
1996 The Candida albicans PKC1 gene encodes a protein kinase C homolog necessary for cellular integrity but not dimorphism. Yeast 12 741 756
33. MongeRA
RomanE
NombelaC
PlaJ
2006 The MAP kinase signal transduction network in Candida albicans. Microbiology 152 905 912
34. BlankenshipJR
FanningS
HamakerJJ
MitchellAP
2010 An extensive circuitry for cell wall regulation in Candida albicans. PLoS Pathog 6 e1000752
35. MarkovichS
YekutielA
ShalitI
ShadkchanY
OsherovN
2004 Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob Agents Chemother 48 3871 3876
36. Reinoso-MartinC
SchullerC
Schuetzer-MuehlbauerM
KuchlerK
2003 The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell 2 1200 1210
37. WalkerLA
MunroCA
de BruijnI
LenardonMD
McKinnonA
2008 Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog 4 e1000040
38. RogersB
DecottigniesA
KolaczkowskiM
CarvajalE
BalziE
2001 The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J Mol Microbiol Biotechnol 3 207 214
39. WhiteTC
1997 Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41 1482 1487
40. WhiteTC
1997 The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans. Antimicrob Agents Chemother 41 1488 1494
41. WhiteTC
PfallerMA
RinaldiMG
SmithJ
ReddingSW
1997 Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis 3 Suppl 1 S102 109
42. EppE
VanierG
HarcusD
LeeAY
JansenG
Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence. PLoS Pathog 6 e1000753
43. HerbertJM
AugereauJM
GleyeJ
MaffrandJP
1990 Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172 993 999
44. MarxMH
PiantadosiC
NosedaA
DanielLW
ModestEJ
1988 Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine. J Med Chem 31 858 863
45. SussmanA
HussK
ChioLC
HeidlerS
ShawM
2004 Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening. Eukaryot Cell 3 932 943
46. SugawaraF
StrobelS
StrobelG
LarsenRD
BerglundDL
1991 The structure and biological activity of cercosporamide from Cercosporidium henningsii. J Org Chem 56 909 910
47. OmuraS
IwaiY
HiranoA
NakagawaA
AwayaJ
1977 A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot (Tokyo) 30 275 282
48. WatanabeM
ChenCY
LevinDE
1994 Saccharomyces cerevisiae PKC1 encodes a protein kinase C (PKC) homolog with a substrate specificity similar to that of mammalian PKC. J Biol Chem 269 16829 16836
49. WhiteTC
MarrKA
BowdenRA
1998 Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11 382 402
50. LevinDE
FieldsFO
KunisawaR
BishopJM
ThornerJ
1990 A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62 213 224
51. YoshidaS
IkedaE
UnoI
MitsuzawaH
1992 Characterization of a staurosporine- and temperature-sensitive mutant, stt1, of Saccharomyces cerevisiae: STT1 is allelic to PKC1. Mol Gen Genet 231 337 344
52. Navarro-GarciaF
EismanB
FiuzaSM
NombelaC
PlaJ
2005 The MAP kinase Mkc1p is activated under different stress conditions in Candida albicans. Microbiology 151 2737 2749
53. JungUS
LevinDE
1999 Genome-wide analysis of gene expression regulated by the yeast cell wall integrity signalling pathway. Mol Microbiol 34 1049 1057
54. BaetzK
MoffatJ
HaynesJ
ChangM
AndrewsB
2001 Transcriptional coregulation by the cell integrity mitogen-activated protein kinase Slt2 and the cell cycle regulator Swi4. Mol Cell Biol 21 6515 6528
55. KamadaY
JungUS
PiotrowskiJ
LevinDE
1995 The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response. Genes Dev 9 1559 1571
56. BonillaM
CunninghamKW
2003 Mitogen-activated protein kinase stimulation of Ca(2+) signaling is required for survival of endoplasmic reticulum stress in yeast. Mol Biol Cell 14 4296 4305
57. BonillaM
NastaseKK
CunninghamKW
2002 Essential role of calcineurin in response to endoplasmic reticulum stress. Embo J 21 2343 2353
58. HomannOR
DeaJ
NobleSM
JohnsonAD
2009 A phenotypic profile of the Candida albicans regulatory network. PLoS Genet 5 e1000783
59. ReedyJL
FillerSG
HeitmanJ
2010 Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. Fungal Genet Biol 47 107 116
60. RoyJ
LiH
HoganPG
CyertMS
2007 A conserved docking site modulates substrate affinity for calcineurin, signaling output, and in vivo function. Mol Cell 25 889 901
61. Stathopoulos-GerontidesA
GuoJJ
CyertMS
1999 Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev 13 798 803
62. RobbinsN
CollinsC
MorhayimJ
CowenLE
2010 Metabolic control of antifungal drug resistance. Fungal Genet Biol 47 81 93
63. KarababaM
ValentinoE
PardiniG
CosteAT
BilleJ
2006 CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol 59 1429 1451
64. MillsonSH
TrumanAW
KingV
ProdromouC
PearlLH
2005 A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryot Cell 4 849 860
65. ShapiroRS
UppuluriP
ZaasAK
CollinsC
SennH
2009 Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol 19 621 629
66. CowenLE
SinghSD
KohlerJR
CollinsC
ZaasAK
2009 Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A 106 2818 2823
67. BaderT
BodendorferB
SchroppelK
MorschhauserJ
2003 Calcineurin is essential for virulence in Candida albicans. Infect Immun 71 5344 5354
68. BlankenshipJR
HeitmanJ
2005 Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect Immun 73 5767 5774
69. SanglardD
IscherF
MarchettiO
EntenzaJ
BilleJ
2003 Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48 959 976
70. MunroCA
SelvagginiS
de BruijnI
WalkerL
LenardonMD
2007 The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol Microbiol 63 1399 1413
71. KumamotoCA
2008 Molecular mechanisms of mechanosensing and their roles in fungal contact sensing. Nat Rev Microbiol 6 667 673
72. GouldCM
KannanN
TaylorSS
NewtonAC
2009 The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail. J Biol Chem 284 4921 4935
73. McClellanAJ
XiaY
DeutschbauerAM
DavisRW
GersteinM
2007 Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 131 121 135
74. ZhaoR
DaveyM
HsuYC
KaplanekP
TongA
2005 Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell 120 715 727
75. Diez-OrejasR
MoleroG
Navarro-GarciaF
PlaJ
NombelaC
1997 Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect Immun 65 833 837
76. AranaDM
Alonso-MongeR
DuC
CalderoneR
PlaJ
2007 Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans. Cell Microbiol 9 1647 1659
77. KumamotoCA
2005 A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci U S A 102 5576 5581
78. GerikKJ
BhimireddySR
RyerseJS
SpechtCA
LodgeJK
2008 PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot Cell 7 1685 1698
79. GonelliA
MischiatiC
GuerriniR
VoltanR
SalvadoriS
2009 Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem 9 498 509
80. MackayHJ
TwelvesCJ
2007 Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 7 554 562
81. BlankenshipJR
SteinbachWJ
PerfectJR
HeitmanJ
2003 Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. Curr Opin Investig Drugs 4 192 199
82. SteinbachWJ
ReedyJL
CramerRAJr
PerfectJR
HeitmanJ
2007 Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5 418 430
83. KarrAL
KarrDB
StrobelGA
1974 Isolation and partial characterization of four host-specific toxins of Helminthosporium maydis (Race T). Plant Physiol 53 250 257
84. BurtET
DalyR
HogansonD
TsirulnikovY
EssmannM
2003 Isolation and partial characterization of Hsp90 from Candida albicans. Ann Clin Lab Sci 33 86 93
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- The Transcription Factor Rbf1 Is the Master Regulator for -Mating Type Controlled Pathogenic Development in
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia